EXONEURAL MEDICINE PLATFORM Trademark

Trademark Overview

On Friday, October 11, 2019, a trademark application was filed for EXONEURAL MEDICINE PLATFORM with the United States Patent and Trademark Office. The USPTO has given the EXONEURAL MEDICINE PLATFORM trademark a serial number of 88651546. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, June 6, 2022. This trademark is owned by Cygnal Therapeutics, Inc.. The EXONEURAL MEDICINE PLATFORM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; Platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals
exoneural medicine platform

General Information

Serial Number88651546
Word MarkEXONEURAL MEDICINE PLATFORM
Filing DateFriday, October 11, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, June 6, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements

Disclaimer with Predetermined Text"MEDICINE PLATFORM"
Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; Platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 17, 2019
Primary Code042
First Use Anywhere DateTuesday, October 8, 2019
First Use In Commerce DateTuesday, October 8, 2019

Trademark Owner History

Party NameCygnal Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameCygnal Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, June 6, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, June 6, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, June 6, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, November 22, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 22, 2021FINAL REFUSAL E-MAILED
Monday, November 22, 2021SU - FINAL REFUSAL - WRITTEN
Tuesday, November 16, 2021ASSIGNED TO EXAMINER
Wednesday, October 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 1, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 1, 2021NON-FINAL ACTION E-MAILED
Tuesday, June 1, 2021SU - NON-FINAL ACTION - WRITTEN
Thursday, May 6, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 21, 2021USE AMENDMENT FILED
Thursday, May 6, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 21, 2021TEAS STATEMENT OF USE RECEIVED
Friday, March 26, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 26, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 20, 2020SOU EXTENSION 1 GRANTED
Tuesday, October 20, 2020SOU EXTENSION 1 FILED
Tuesday, October 20, 2020TEAS EXTENSION RECEIVED
Tuesday, October 20, 2020ASSIGNED TO EXAMINER
Tuesday, April 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2020ASSIGNED TO LIE
Friday, January 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 17, 2020EXAMINER'S AMENDMENT ENTERED
Friday, January 17, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 17, 2020EXAMINERS AMENDMENT E-MAILED
Friday, January 17, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, January 16, 2020ASSIGNED TO EXAMINER
Wednesday, December 18, 2019TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, December 19, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, December 18, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

platform medicine exoneural research development field biotechnology pharmaceuticals computational bioinformatics genomics scientific biology